FONTEYNE MARC OSTEOPATHIE
ActiveSummary
The annual accounts of FONTEYNE MARC OSTEOPATHIE for fiscal year 2025 show a net loss of 81% of total assets and of 55% of the equity at the start of that year. The 2025 annual accounts show equity of €20k and a net result of €-24k. Equity is shrinking by ~2.7% per year across the filed fiscal years. Its solvency ranks better than 54% of 16546 sector peers (fiscal year 2025). The company has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
59
/ 100
Fair
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. A net loss of at least half of total assets or of the equity at the start of the financial year caps the score. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability5▼-90
Solvency92▼-8
Growth32▼-20
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €1k at 30 days only on tighter terms
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity ample (current ratio 2.8 against 4.3 in 2024; short-term debt: 30.9% and cash: 80.5% of total assets), and 32.6% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
67.4%
Return on assets
-81.1%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-08-2026, 27 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 9 filingsDeviation from the deadline
2025
27 d late
2024
28 d late
2023
26 d late
2022
94 d late
2021
31 d late
2020
89 d late
2019
145 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€20k▼ 54.6%
2024 · €44k
2018: €34k
2019: €42k
2020: €51k
2021: €-34k
2022: €65k
2023: €33k
2024: €44k
2018 → 2025
Total assets
€29k▼ 45.0%
2024 · €53k
2018: €57k
2019: €59k
2020: €69k
2021: €72k
2022: €83k
2023: €48k
2024: €53k
2018 → 2025
Net result
€-24k
2024 · €11k
2018: €12k
2019: €8k
2020: €9k
2021: €-85k
2022: €4k
2023: €-32k
2024: €11k
2018 → 2025
Working capital
€16k▼ 42.4%
2024 · €28k
2018: €8k
2019: €16k
2020: €18k
2021: €-67k
2022: €44k
2023: €12k
2024: €28k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€-34k-€65k€33k▼ 49.6%€44k▲ 33.8%€20k▼ 54.6%
Operating result€-84k-€5k€7k▲ 40.4%€12k▲ 69.2%€23k▲ 97.8%
Net result€-85k-€4k€-32k€11k€-24k
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen four years in a row; 2025 is 98% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €29k
Fixed assets
€4k ▼ 76.0%
Current assets
€25k ▼ 31.2%
Equity and liabilities €29k
Equity
€20k ▼ 54.6%
Debt
€10k ▼ 1.9%
Debt's share of the balance-sheet total rises from 18.3% to 32.6%. Equity and debt are lower.
Key figures and ratios
EBITDA
€27k▲
2024 · €16k
Cash flow
€-20k▼
2024 · €15k
Current ratio
2.80▼
2024 · 4.30
Debt to equity
0.48▲
2024 · 0.22
ROE
-120.4%▼
2024 · 25.3%
ROA
-81.1%▼
2024 · 20.7%
Interest coverage
0.57▼
2024 · 69.48
Debt ≤ 1 year
€9k▲
2024 · €9k
Income taxes
€141▼
2024 · €847
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 48 lines
Balance sheet
Code20242025
Assets
Total assets20/58€53k€29k▼
Fixed assets21/28€16k€4k▼
Tangible fixed assets22/27€6k€4k▼
Land and buildings22€5k€3k▼
Plant, machinery and equipment23€378€189▼
Furniture and vehicles24€668€1k▲
Financial fixed assets28€10k€0▼
Current assets29/58€37k€25k▼
Amounts receivable within one year40/41€23k€0▼
Trade receivables40€18k€0▼
Other amounts receivable41€4k€0▼
Cash at bank and in hand54/58€14k€24k▲
Deferred charges and accrued income490/1€881€2k▲
Equity and liabilities
Total equity and liabilities10/49€53k€29k▼
Equity10/15€44k€20k▼
Contributions10/11€6k€6k=
Reserves13€37k€37k=
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Distributable reserves133€36k€36k=
Profit (loss) carried forward14€0€-24k▼
Amounts payable17/49€10k€10k▼
Amounts payable within one year42/48€9k€9k▲
Trade debts44€2k€2k▲
Suppliers440/4€2k€2k▲
Taxes, remuneration and social security45€7k€987▼
Taxes450/3€7k€987▼
Remuneration and social security454/9€0-
Other amounts payable47/48€0€6k▲
Accrued charges and deferred income492/3€1k€497▼
Income statement
Code20242025
Non-recurring operating income76A€0€165▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4k€3k▼
Other operating charges640/8€628€646▲
Non-recurring operating charges66A€150€0▼
Gross operating margin9900€16k€27k▲
Operating profit (loss)9901€12k€23k▲
Financial income75/76B€294€0▼
Recurring financial income75€294€0▼
Financial charges65/66B€226€47k▲
Recurring financial charges65€226€47k▲
Profit (loss) for the period before taxes9903€12k€-24k▼
Income taxes67/77€847€141▼
Profit (loss) for the period9904€11k€-24k▼
Profit (loss) for the period to be appropriated9905€11k€-24k▼
Appropriation of the result
Profit (loss) to be appropriated9906€7k€-24k▼
Profit (loss) brought forward from the previous period14P€-4k€0▲
Transfer to equity691/2€7k€0▼
To other reserves6921€7k€0▼
The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 27 days late
2025
28-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 28 days late
2024
31-12
Financial
Back to profitnet €11k
Net result €11k after one loss-making year.
31-12
Financial
Liquidity doublescurrent ratio 4.30
Current ratio from 1.78 to 4.30; short-term debt falls from €16k to €9k.
26-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 26 days late
2023
02-11
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 94 days late
2022
31-12
Financial
Back to profitnet €4k
Net result €4k after one loss-making year.
31-12
Financial
Liquidity times 11current ratio 3.95
Current ratio from 0.35 to 3.95; short-term debt falls from €104k to €15k.
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
2021
31-12
Financial
Weakest financial yearnet €-85k ▼1021%
Net result drops to €-85k, the lowest in the series; recovery starts the following year.
28-10
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 89 days late
2020
23-12
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 145 days late
2019
31-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 31 days late
2018
27-09
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 58 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Vorst · 1 establishment unit since 2017
Ground area
2,288 m²
Building footprint
410 m²
Volume, LiDAR
6,293 m³
2 parcels, Brussels · tallest building 19.1 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
FONTEYNE MARC OSTEOPATHIE
since 20172.260.900.546
2 parcels
Brussels
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21384D0280/00V011 | Brussels | 2,071 m² | 1 · 343 m² | 19.1 m · 5 fl. |
| 21384D0280/00L037 | Brussels | 217 m² | 1 · 67 m² | 17.9 m · 4 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
254900RVNU2GM8K0RC86
Similar companies · same sector, comparable size
DR. INE LANCKRIET
BE 1017.930.272
Zulte · Eq €19,819
Dr. Van Landeghem Charlotte
BE 0802.411.318
Lebbeke · Eq €19,786
Dokter VDVL
BE 1028.509.806
Gent · Eq €19,874
DR. ISABELLE DE MEYERE
BE 0760.843.848
Kortrijk · Eq €19,730
Dr. Uyttersprot A-Au, huisarts
BE 0645.717.518
Gent · Eq €19,652
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 3,260 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded25-01-2017
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
86951Physiotherapy
Sources
Crossroads Bank for EnterprisesNational Bank · 9 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.